Live Breaking News & Updates on Catheterisation Laboratory In Columbus Hospital

Elixir Medical’s 24-Month Clinical Results for DynamX Bioadaptor Showed Strong Safety Profile, With No Clinical Events
January 28, 2021
The DynamX Bioadaptor is a new class of treatment for Coronary Artery Disease.
SINGAPORE, January 28, 2021 /EINPresswire.com/ Elixir Medical’s 24-Month Clinical Results for DynamX Bioadaptor Showed Strong Safety Profile, With No Clinical Events
Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, announced the 24-month clinical results for the DynamX™ Coronary Bioadaptor System, recently presented at 30th Annual Live Interventions in Vascular Endotherapy conference organised by the National Heart Centre of Singapore (Singapore LIVE). The bioadaptor is the first coronary artery implant that adapts to vessel physiology. ....

United States , Sri Lanka , Soo Teik , National Heart Centre Singapore , Department Of Cardiology , Catheterisation Laboratory In Columbus Hospital , Elixir Medical Corporation , Catheterisation Laboratory , National Heart Centre , Professor Of Cardiology At Humanitas Medical School , Singapore Heart Foundation , National Heart Centre Of Singapore , Mileage Communications Pte Ltd , Dynamx Bioadaptor , Coronary Artery , Elixir Medical , Month Clinical Results , Dynamx Bioadaptor Showed Strong Safety Profile , With No Clinical , Coronary Bioadaptor System , Annual Live Interventions , Antonio Colombo , Humanitas Medical School , Senior Consultant , Interventional Cardiology , Humanitas Research Hospital ,